Table 2. Associations between CD204+ST Mφ density and the clinicopathological characteristics of UCB.
CD204+ST Mφ Density | ||||
---|---|---|---|---|
Variable | Low | High | R | P |
No. of patients | 151 (50%) | 151 (50%) | ||
Age, years | 0.086 | 0.135 | ||
≤60 | 85 (28%) | 72 (24%) | ||
>60 | 66 (22%) | 79 (26%) | ||
Gender | 0.039 | 0.499 | ||
Male | 133 (44%) | 129 (43%) | ||
Female | 18 (6%) | 22 (7%) | ||
Tumor size | 0.183 | 0.001 | ||
≤3 cm | 129 (43%) | 106 (35%) | ||
>3 cm | 22 (7%) | 45 (15%) | ||
Multifocality | 0 | 1 | ||
Unifocal | 107 (35%) | 107 (35%) | ||
Multifocal | 44 (15%) | 44 (15%) | ||
Tumor stage | 0.333 | <0.0001 | ||
Ta–T1 | 129 (43%) | 83 (27%) | ||
T2–T4 | 22 (7%) | 68 (23%) | ||
Nodal metastasis | 0.207 | <0.0001 | ||
N0 | 150 (50%) | 136 (45%) | ||
N1–N2 | 1 (0%) | 15 (5%) | ||
Histological grade | 0.315 | <0.0001 | ||
Low | 111 (37%) | 64 (21%) | ||
High | 40 (13%) | 87 (29%) |
Abbreviations: UCB, urothelial cell carcinoma of the bladder; CD204+ST Mφ, CD204+ Mφ in stromal regions.
Significant P-values are shown in bold font.